Showing 6081-6090 of 23168 results for "".
Molecular Neurobiology in Spinal Cord Injuries and Strokes
https://reachmd.com/programs/clinicians-roundtable/molecular-neurobiology-in-spinal-cord-injuries-and-strokes/2432/John A. Kessler MD is Davee Professor of Stem Cell Biology and Chairman of the Davee Department of Neurology, Northwestern University Medical School. He discusses applying molecular neurobiology to clinical problems of spinal cord injury and stroke. Dr. Bruce Bloom hosts.Personalizing Peanut Oral Immunotherapy by Baseline Reactivity
https://reachmd.com/programs/clinicians-roundtable/personalizing-peanut-oit-by-reactivity/54219/Based on a randomized study, children with higher baseline thresholds of peanut reactivity achieved markedly higher rates of sustained unresponsiveness after oral immunotherapy compared with untreated peers. Learn more about this study and its clinical implications with Dr. Scott H. Sicherer. Not onData Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
https://reachmd.com/programs/neurofrontiers/Data-Equity-in-Action-Largest-Real-World-MS-Analysis-Confirms-Fumarate-Efficacy-Across-Racial-Groups/36351/Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
https://reachmd.com/programs/living-rheum/understanding-preload-deficiency-in-sle-a-new-look-at-fatigue-and-exercise-intolerance/32795/Fatigue and exercise intolerance in patients with systemic lupus erythematosus (SLE) may persist even when disease activity is controlled, and preload deficiency could be an overlooked cause. In this expert-led discussion, Drs. Luigi Adamo and Andrea Fava share insights from their research, hRethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
https://reachmd.com/programs/neurofrontiers/novel-mechanisms-in-schizophrenia-guidelines/36641/Schizophrenia treatment has long centered on D2 receptor antagonism, but is that still enough? With novel, mechanism-based therapies now available, such as muscarinic agonists, TAAR1 agonists, and glutamate modulators, the case for modernizing current guidelines is growing stronger. Joining Dr. CharComparing COVID-19 Vaccine Strategies: What Projections Reveal
https://reachmd.com/programs/clinicians-roundtable/comparing-covid-19-vaccine-strategies/48841/A recent comprehensive modeling study evaluated the potential impacts of varying COVID-19 vaccine recommendation strategies across different levels of viral evolution for the 2024–2025 season. Learn about the findings and their implications for vaccination policy with Dr. Sara Loo, an Assistant ScieThe Maternal Brain’s Role in Bone Health: Exploring CCN3’s Potential Power
https://reachmd.com/programs/frontlines-osteoporosis/the-maternal-brains-role-in-bone-health-exploring-cnn3s-potential-power/32343/Based on a recent study’s findings, CCN3 is a hormone released from the maternal brain that triggers skeletal stem cells to form new bone—a discovery that could transform osteoporosis treatment by targeting the condition at its root. Joining Ms. Ashley Baker to explore the key findings and clinicalQuality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
https://reachmd.com/programs/frontlines-schizophrenia/quality-of-life-in-schizophrenia-patients-challenges-and-practical-approaches-to-care/30030/Tune in to find out how we can mitigate quality-of-life impacts on schizophrenia patients.Diving into Drug-Induced Liver Injury: What We Need to Know
https://reachmd.com/programs/gi-insights/diving-into-drug-induced-liver-injury-what-we-need-to-know/13072/Drug-induced liver injury continues to be one of the leading causes of acute liver failure. Here’s how you can spot it early on.At the Heart of Healthcare: Addressing the Future of Cardiology Care
https://reachmd.com/programs/heart-matters/at-the-heart-of-healthcare-addressing-the-future-of-cardiology-care/12055/With changes constantly being made in the field of cardiology, what can we expect to see in the future?